Filing Flows › GeoVax Labs (GOVX) › R&D spending
GeoVax Labs (GOVX) R&D spending by quarter
GeoVax Labs' R&D spending was $4.7M in Q2 2025 (second quarter 2025), -12% from Q1 2025. Over the last 3 quarters it ranged from $4.7M (Q2 2025) to $7.6M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2025 | $4.7M | -12% | — |
| Q1 2025 | $5.4M | -30% | — |
| Q4 2024 | $7.6M | — | — |
Q2 2025 at a glance
GeoVax Labs, Q2 2025: revenue $852K (+184% year over year), operating margin -635.8%, net loss $5.4M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is GeoVax Labs' R&D spending?
GeoVax Labs' R&D spending was $4.7M in Q2 2025 (second quarter 2025), -12% from Q1 2025.
How has GeoVax Labs' R&D spending changed?
Over the last 3 quarters it ranged from $4.7M (Q2 2025) to $7.6M (Q4 2024).